Inventor · disambiguated record
Mitsuyoshi Azuma
Also filed as: AZUMA MITSUYOSHI
18 granted patents·5 pending applications·171 citations·filing 1986–2021
94Inventor score
Files withSENJU PHARMA CO16NAKAJIMA TAKESHI3TAKAYAMA YOSHIKO2TAKEDA CHEMICAL INDUSTRIES LTD1YABUTA CHIHO1
Top patents by PatentIndex Score
23 records- 0187US6649625B2Agent for prophylaxis and treatment of glaucomaSENJU PHARMA CO·Filed 2002·Granted Nov 18, 2003·27 cites·9 claims
- 0285US8268794B2Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitorNAKAJIMA TAKESHI·Filed 2008·Granted Sep 18, 2012·10 cites·6 claims
- 0383US7485654B2Corneal perception recovery drug containing amide compoundSENJU PHARMA CO·Filed 2005·Granted Feb 3, 2009·8 cites·3 claims
- 0480US6057290AAngiogenesis inhibitorSENJU PHARMA CO·Filed 1996·Granted May 2, 2000·23 cites·26 claims
- 0578US6673812B1Preventives/remedies for glaucomaSENJU PHARMA CO·Filed 1999·Granted Jan 6, 2004·42 cites·9 claims
- 0677US8383130B2Partial peptide of lacritinSENJU PHARMA CO·Filed 2009·Granted Feb 26, 2013·2 cites·21 claims
- 0771US7956072B2Agent for repairing corneal sensitivity containing amide compoundSENJU PHARMA CO·Filed 2008·Granted Jun 7, 2011·1 cites·6 claims
- 0870US8518412B2Partial peptide of lacritinNAKAJIMA TAKESHI·Filed 2010·Granted Aug 27, 2013·2 cites·5 claims
- 0965US4794124ATherapeutic composition for diabetic complicationsSENJU PHARMA CO·Filed 1986·Granted Dec 27, 1988·11 cites·1 claims
- 1058US5935959APiperazine derivatives and use as cysteine inhibitorsSENJU PHARMA CO·Filed 1996·Granted Aug 10, 1999·9 cites·9 claims
- 1154US2023390235A1Therapeutic agent for covid-19SENJU PHARMA CO·Filed 2021·Application pending·0 cites
- 1252US6582932B1Calpain and DNA encoding the sameSENJU PHARMA CO·Filed 1999·Granted Jun 24, 2003·9 cites·5 claims
- 1351US2010183572A1Cell capable of expressing lacritin at high levelNAKAJIMA TAKESHI·Filed 2008·Application pending·0 cites
- 1450US6551999B1Angiogenesis inhibitorSENJU PHARMA CO·Filed 1999·Granted Apr 22, 2003·3 cites·1 claims
- 1549US4826872APharmaceutical composition for treatment of cataractTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1987·Granted May 2, 1989·12 cites·10 claims
- 1648US9562231B2Therapeutic agent for corneal epithelial disorderSENJU PHARMA CO·Filed 2014·Granted Feb 7, 2017·0 cites·13 claims
- 1747US6214800B1Angiogenesis inhibitorSENJU PHARMA CO·Filed 1999·Granted Apr 10, 2001·3 cites·21 claims
- 1846US8637544B2Neurite formation promoterYABUTA CHIHO·Filed 2008·Granted Jan 28, 2014·0 cites·11 claims
- 1944US2007093513A1Agent for repairing corneal perceptionSENJU PHARMA CO·Filed 2004·Application pending·0 cites
- 2043US6423691B1Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytographySENJU PHARMA CO·Filed 1999·Granted Jul 23, 2002·7 cites·18 claims
- 2142US2006234922A1Remedy for corneal failureTAKAYAMA YOSHIKO·Filed 2003·Application pending·0 cites
- 2237US6342531B1Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairmentSENJU PHARMA CO·Filed 1999·Granted Jan 29, 2002·2 cites·9 claims
- 2336US2011212899A1Corneal Neuritogenesis Promoter Containing Pacap and Its DerivativeTAKAYAMA YOSHIKO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mitsuyoshi Azuma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →